
Orpheus Bioscience
Founded Year
2016Stage
Unattributed - II | AliveTotal Raised
$4.42MLast Raised
$3.16M | 4 yrs agoAbout Orpheus Bioscience
Orpheus Bioscience focuses on the development of treatments for autoimmune diseases. In pursuit of this goal, the company develops the PantId, a protein-based therapeutic for the elimination of pathological immune cells and antibodies from patients. PantIds are specifically designed for each autoimmune disease, resulting in a product with fewer adverse effects than conventional immunosuppressive therapeutics.
Orpheus Bioscience Patents
Orpheus Bioscience has filed 1 patent.
The 3 most popular patent topics include:
- Autoimmune diseases
- Clusters of differentiation
- Immune system

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
3/23/2018 | Immunology, Immune system, Clusters of differentiation, T cells, Autoimmune diseases | Application |
Application Date | 3/23/2018 |
---|---|
Grant Date | |
Title | |
Related Topics | Immunology, Immune system, Clusters of differentiation, T cells, Autoimmune diseases |
Status | Application |
Orpheus Bioscience Frequently Asked Questions (FAQ)
When was Orpheus Bioscience founded?
Orpheus Bioscience was founded in 2016.
Where is Orpheus Bioscience's headquarters?
Orpheus Bioscience's headquarters is located at 9385 Discovery Blvd., Manassas.
What is Orpheus Bioscience's latest funding round?
Orpheus Bioscience's latest funding round is Unattributed - II.
How much did Orpheus Bioscience raise?
Orpheus Bioscience raised a total of $4.42M.